SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
SEC Accession No. 9999999997-24-002666
Filing Date
2024-05-14
Accepted
2024-05-15 08:05:08
Documents
1
Items
Item 20240515:
Item 20240514:

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REVOKED 212212
  Complete submission text file 9999999997-24-002666.txt   293825
Mailing Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116 (617) 600-3497
EPIRUS Biopharmaceuticals, Inc. (Filer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: REVOKED | Act: 34 | File No.: 000-51171 | Film No.: 24947254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)